Large-scale testing (Phase 3)Study completedNCT04516096
What this trial is testing
A Compassionate Use Protocol of AMX0035 for Treatment of Patients With Amyotrophic Lateral Sclerosis (ALS)
Who this might be right for
Amyotrophic Lateral Sclerosis
Amylyx Pharmaceuticals Inc. 28